Professor Dolores Schendel is a leading expert in T cell research and immunotherapy, with decades of experience and nearly 200 scientific publications. She has served on the scientific review boards of prestigious organisations, including the German Research Foundation and the European Research Council. Since 2022, Professor Schendel has been the chief scientific officer of Medigene, a role she previously held after Medigene acquired her company, Trianta Immunotherapies, in 2014. From 1998 to 2013, she was the director of the Institute of Molecular Immunology at the German Research Centre for Environmental Health in Munich. Her work has significantly contributed to advancing immunotherapy treatments.